Stocks
Immunomedics (IMMU) EBITDA margin US GAAP (year values) |
|||||||||
| FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -385.4% | -800.9% | -1 790% | -4 748% | -11 555% | -1 247% | ||
| Changes by years, y/y, % | -162pp | -415pp | -989pp | -2 958pp | -6 807pp | +120.2% | |||
Immunomedics. EBITDA margin, %
Immunomedics. EBITDA margin, changes, pp
Immunomedics (IMMU) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2017Q4 | FY2018Q1 | FY2018Q2 | FY2020Q1 | FY2020Q2 | LTM ? | |||
| EBITDA margin, % | ? | -305.5% | -5 046% | -27 742% | -255.3% | -1 247% | ||
| Changes by years, y/y, % | +5 641pp | -681pp | -19 706pp | |||||
| Changes by quarters, q/q, % | +16 478pp | -4 741pp | -22 696pp | +27 742pp | ||||
